Dexmedetomidine Regulates the miR-199a-5p/G6PD Pathway to Induce Ferroptosis and Suppress Malignant Phenotypes in Colorectal Cancer Cells
ZHAO Congwei1, MA Tao1*, FENG Pei1, CHI Hongxin2, DONG Jiali1
This work was to investigate the effects of DEX (dexmedetomidine) on proliferation, migration, invasion, and ferroptosis of colorectal cancer cells, and to elucidate the potential mechanisms of the miR-199a 5p/G6PD (glucose-6-phosphate dehydrogenase) axis in this process. Human colorectal cancer cell lines HT29 and SW480 were used for in vitro experiments. Cell viability was assessed by CCK-8 assay; colony formation assay was used to evaluate cell proliferation; wound healing and Transwell assays were performed to detect cell migra tion and invasion, respectively; Western blot was employed to detect the expression levels of EMT (epithelial mesenchymal transition)-related proteins, including E-cadherin (epithelial cadherin), N-cadherin (neural cadherin), and Snail1 (snail family transcriptional repressor 1), as well as ferroptosis-related proteins, including GPX4 (glu tathione peroxidase 4), SLC7A11 (solute carrier family 7 member 11), NRF2 (nuclear factor erythroid 2-related factor 2), and TFRC (transferrin receptor protein 1); intracellular ROS (reactive oxygen species) levels were mea sured by fluorescence probe method; GSH (glutathione) content was detected by colorimetric method; intracel lular Fe2+ levels were measured by fluorescence probe method; the ferroptosis inhibitor Fer-1 (ferrostatin-1) was used for intervention validation. The mRNA expression levels of miR-199a-5p and G6PD were detected by real time quantitative PCR; dual-luciferase reporter assay was performed to verify the targeting relationship between miR-199a-5p and G6PD. Cell groups were as follows: control group (Con), DEX-treated group (100 ng/mL, 24 h), DEX+miR-199a-5p mimic group, DEX+miR-199a-5p inhibitor group, DEX+G6PD overexpression group, and cor responding negative control transfection groups. Compared with the control group, the DEX-treated group showed significantly decreased cell viability, colony formation number, and numbers of migrating and invading cells in both HT29 and SW480 cells (all P<0.01), significantly increased E-cadherin protein expression level (P<0.001), and significantly decreased N-cadherin and Snail1 protein expression levels (both P<0.001); ROS fluorescence intensity and Fe2+ fluorescence intensity were significantly increased (both P<0.001), while GSH content was significantly decreased (P<0.001); the protein expression levels of GPX4, SLC7A11, and NRF2 were significantly decreased (all P<0.001), whereas TFRC protein expression level was significantly increased (P<0.001); Fer-1 intervention signifi cantly reversed the DEX-induced decrease in cell viability (P<0.001). Compared with the control group, the DEX treated group exhibited significantly increased miR-199a-5p expression level (P<0.001) and significantly decreased G6PD mRNA expression level (P<0.001); dual-luciferase reporter assay confirmed that miR-199a-5p could directly target the 3′-untranslated region of G6PD mRNA. Compared with the DEX-treated group, the G6PD overexpression group showed significantly increased cell viability, colony formation number, and numbers of migrating and invading cells (all P<0.01), significantly decreased E-cadherin protein expression level (P<0.001), and significantly increased N-cadherin and Snail1 protein expression levels (both P<0.001); ROS fluorescence intensity and Fe2+ fluorescence intensity were significantly decreased (both P<0.001), while GSH content was significantly increased (P<0.001); the protein expression levels of GPX4, SLC7A11, and NRF2 were significantly increased (all P<0.001), whereas TFRC protein expression level was significantly decreased (P<0.001). DEX upregulates miR-199a-5p in colorectal cancer cells, which in turn targets and suppresses G6PD, thereby disrupting cellular antioxidant defense and inducing fer roptosis. Activation of ferroptosis serves as a key mediating mechanism through which DEX inhibits the prolifera tion, migration, and invasion of colorectal cancer cells. These findings suggest that the miR-199a-5p/G6PD axis is a potential regulatory node underlying the ferroptosis-inducing and anti-colorectal cancer effects of DEX.



CN
EN